← Back to headlines
Allogene Therapeutics Announces $175M Stock Offering
Allogene Therapeutics has priced a $175 million stock offering at $2 per share, as reported by Seeking Alpha.
15 Apr, 06:05 — 15 Apr, 06:05
Sources
Showing 1 of 1 sources
Allogene Therapeutics has priced a $175 million stock offering at $2 per share, as reported by Seeking Alpha.
